In the present study, we evaluated the therapeutic effect of SHED on CCl4-induced mouse liver cirrhosis and revealed that SHED administration attenuated liver cirrhosis by alleviating GSDMD-mediated pyroptosis and inflammation. The gene discussed is GSDMD; the disease is cirrhosis of liver.